<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00795808</url>
  </required_header>
  <id_info>
    <org_study_id>UAuckland</org_study_id>
    <nct_id>NCT00795808</nct_id>
  </id_info>
  <brief_title>PCOSMIC Trial - PolyCystic Ovary Syndrome, Metformin for Infertility With Clomiphene</brief_title>
  <acronym>PCOSMIC</acronym>
  <official_title>Multi-Centre Randomised Controlled Trial of the Effectiveness of Metformin and Clomiphene Citrate for Treating Anovulatory Infertility in Women With Polycystic Ovary Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Auckland, New Zealand</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Auckland Medical Research Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Mercia Barnes Trust of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Auckland, New Zealand</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      1. Metformin increases the pregnancy rate when added to the standard treatment of&#xD;
           anovulatory polycystic ovary syndrome (PCOS).&#xD;
&#xD;
        2. Metformin in combination with clomiphene, is more effective than clomiphene alone or&#xD;
           metformin alone improves fertility outcomes in women with PCOS of reasonably healthy&#xD;
           body weight (BMI &lt;/= 32).&#xD;
&#xD;
        3. Metformin improves fertility outcomes in women with BMI &gt; 32 with PCOS.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2003</start_date>
  <completion_date type="Actual">October 2008</completion_date>
  <primary_completion_date type="Actual">October 2008</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical pregnancy</measure>
    <time_frame>within 6 calendar months of randomisation</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Live birth</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events</measure>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">171</enrollment>
  <condition>Polycystic Ovary Syndrome</condition>
  <arm_group>
    <arm_group_label>BMI &gt; 32</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Women with BMI &gt; 32</description>
  </arm_group>
  <arm_group>
    <arm_group_label>BMI &lt;/= 32</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Women with BMI &lt;/= 32</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Metformin</intervention_name>
    <description>500mg tds for 6 months</description>
    <arm_group_label>BMI &gt; 32</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>One tablet tds for 6 months</description>
    <arm_group_label>BMI &gt; 32</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Metformin + Clomiphene</intervention_name>
    <description>500mg tds + Ovulatory dose for 6 months</description>
    <arm_group_label>BMI &lt;/= 32</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Metformin</intervention_name>
    <description>500mg tds for 6 months</description>
    <arm_group_label>BMI &lt;/= 32</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Clomiphene</intervention_name>
    <description>Ovulatory dose for 6 months</description>
    <arm_group_label>BMI &lt;/= 32</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Women between the age of 18 and 39 years inclusive.&#xD;
&#xD;
          -  Anovulatory infertility of duration at least 12 months.&#xD;
&#xD;
          -  Polycystic ovary syndrome, based on Rotterdam consensus criteria.&#xD;
&#xD;
          -  Normal serum prolactin, thyroid function and 17-hydroxyprogesterone.&#xD;
&#xD;
          -  Normal serum prolactin, thyroid function and 17-hydroxyprogesterone;&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Presence of any other significant infertility factor including male factor, known&#xD;
             tubal disease or history of an ectopic pregnancy, known endometriosis affecting the&#xD;
             fallopian tubes or ovaries.&#xD;
&#xD;
          -  Already taking oral hypoglycaemics.&#xD;
&#xD;
          -  Diabetics receiving treatment.&#xD;
&#xD;
          -  Renal impairment&#xD;
&#xD;
          -  Chronic hepatic disease&#xD;
&#xD;
          -  Cardiac Disease&#xD;
&#xD;
          -  Alcohol dependency&#xD;
&#xD;
          -  Pre-disposition to lactic acidosis&#xD;
&#xD;
          -  Previous ovarian drilling procedure, gonadotrophin injection therapy, IUI&#xD;
             (intrauterine insemination) or IVF ( in vitro fertilisation).&#xD;
&#xD;
          -  For those women who have had previous fertility treatment, the following would be&#xD;
             excluded:&#xD;
&#xD;
               -  Women who have had &gt; 5 cycles of clomiphene citrate&#xD;
&#xD;
               -  Women who have had &gt; 5 months metformin treatment previously&#xD;
&#xD;
               -  Women who have proven to be resistant to 100mg or more of clomiphene citrate.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>39 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Neil P Johnson, FRANZCOG</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Auckland, fertility Plus &amp; Repromed Auckland</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Auckland</name>
      <address>
        <city>Auckland</city>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>New Zealand</country>
  </location_countries>
  <verification_date>November 2008</verification_date>
  <study_first_submitted>November 20, 2008</study_first_submitted>
  <study_first_submitted_qc>November 20, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 21, 2008</study_first_posted>
  <last_update_submitted>November 20, 2008</last_update_submitted>
  <last_update_submitted_qc>November 20, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 21, 2008</last_update_posted>
  <responsible_party>
    <name_title>Associate Professor Neil Johnson</name_title>
    <organization>University of Auckland, Fertility Plus and Repromed Auckland</organization>
  </responsible_party>
  <keyword>Polycystic ovary syndrome</keyword>
  <keyword>PCOS</keyword>
  <keyword>Anovulation</keyword>
  <keyword>Infertility</keyword>
  <keyword>Anovulatory polycystic ovary syndrome (PCOS)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Polycystic Ovary Syndrome</mesh_term>
    <mesh_term>Infertility</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metformin</mesh_term>
    <mesh_term>Clomiphene</mesh_term>
    <mesh_term>Enclomiphene</mesh_term>
    <mesh_term>Zuclomiphene</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

